{"id":71434,"date":"2025-09-18T10:19:58","date_gmt":"2025-09-18T10:19:58","guid":{"rendered":"https:\/\/kanboapp.com\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/"},"modified":"2025-09-18T10:19:58","modified_gmt":"2025-09-18T10:19:58","slug":"navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles","status":"publish","type":"page","link":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/","title":{"rendered":"Navigating Pharmaceutical Challenges: Enhancing Risk Visibility to Overcome Compliance Competition and Safety Obstacles"},"content":{"rendered":"<style> @media(min-width:1728px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{    flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;}  .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy { margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media(min-width: 1440px) and (max-width:1727px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 1024px) and (max-width:1439px) { .tytulek{font-size:34px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:8px 8px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:35%!important;} .compact-nag{display:none!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.25px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:17px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:14px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2{ display:block!important; } .pasek-lewy {  margin-left:7%!important; } .pasek-prawy {  margin-right:7%!important; } } @media (min-width: 782px) and (max-width:1023px) { .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;}  .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:60%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 32px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:block!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:32px!important; } .pasek-prawy {margin-right:32px!important; } } @media (max-width:781px) {  .tytulek{font-size:25px!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 16px!important; margin-right: 16px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:14px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 4px; border-radius: 8px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:14px!important; line-height: 150% !important;} .menu-lewe{margin-bottom: 8px!important;} .kolumna-tekst{flex-basis:100%!important;} .compact-nag{display:block!important; } .naglowek-duzy {margin-bottom:24px!important; margin-top: 48px!important; font-size:19px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.19px!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 32px!important; font-size:25px!important; font-style:normal; font-weight:600!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:14px!important;line-height:160%!important;margin-bottom:24px!important;} .tekst-para-maly {font-size:12px!important;line-height:160%!important;margin-bottom:24px!important;} .prawy-tytul{font-size:16px!important;} .prawy-tekst {font-size:13px!important;} .prawy-link a{font-size:16px!important;} .spis { display:none!important; } .spis2 { display:none!important; } .pasek-lewy { margin-left:16px!important; } .pasek-prawy {margin-right:16px!important; } } .prawy-link a:hover { color:#145A92!important} .banner { margin-top:80px; margin-bottom:80px; } .jazda-nowsza { position:sticky!important; top: 120px; overflow: auto; max-height: 85vh; }  .fobrazek { margin-bottom: -40px!important; } .sekcja5-przycisk a:hover { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; }  .sekcja5-przycisk a:focus { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; } .vlp-layout-blogs .vlp-block-0 {font-weight: 600!important; } .prawy-tytul-pulpit {font-size:19px!important;} .ct-container-narrow {max-width: 1200px!important;}  :nth-last-child(1 of .tekst-para) {margin-bottom: 0px!important;} <\/style><script> function lewemenu(zm) { var elements = document.getElementsByClassName(\"menu-lewe\"); var i,link1,link2; for (i = 0; i < elements.length; i++) {    link1 = elements[i].getElementsByTagName(\"a\");     link1[0].style.fontWeight = \"600\";     link1[0].style.backgroundColor= \"#FAFAFA\"; } link2 = elements[zm].getElementsByTagName(\"a\"); link2[0].style.fontWeight = \"600\"; link2[0].style.backgroundColor= \"#E9F4FE\"; } <\/script><div class=\"wp-block-getwid-section alignfull alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background has-background\" style=\"background-color:#fafafa\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><div class=\"wp-block-columns alignfull artykul is-layout-flex wp-container-core-columns-is-layout-f96e3eba wp-block-columns-is-layout-flex\" style=\"margin-top:0px;margin-bottom:0px\"><div class=\"wp-block-column pasek-lewy spis jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><p class=\"menu-lewe wp-elements-fcc4415e4e99e96be9a53fa0a78f78b2 wp-block-paragraph\" onclick=\"lewemenu(0)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section1\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section1\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Why change?<\/a><\/p><p class=\"menu-lewe wp-elements-9e439969de8e7ccd504e144fd1b9d46d wp-block-paragraph\" onclick=\"lewemenu(1)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section2\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section2\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Background \/ Definition<\/a><\/p><p class=\"menu-lewe wp-elements-a968db4be8e8facab78501e85d9088c4 wp-block-paragraph\" onclick=\"lewemenu(2)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section3\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section3\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Case-Style Mini-Examples<\/a><\/p><p class=\"menu-lewe wp-elements-6ce5c26b9ae7ef06cf9147b774a9e688 wp-block-paragraph\" onclick=\"lewemenu(3)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section4\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section4\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will change?<\/a><\/p><p class=\"menu-lewe wp-elements-75ca7f4f818ec04c7d0f0e298c62c36b wp-block-paragraph\" onclick=\"lewemenu(4)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section5\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section5\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">What will not change?<\/a><\/p><p class=\"menu-lewe wp-elements-573be12b35cb68f02b5bcb70b36bcb1e wp-block-paragraph\" onclick=\"lewemenu(5)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section6\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section6\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Key management questions (Q\/A)<\/a><\/p><p class=\"menu-lewe wp-elements-d7121002ec5cfea339d88c7b42e07e1a wp-block-paragraph\" onclick=\"lewemenu(6)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section7\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section7\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Atomic Facts<\/a><\/p><p class=\"menu-lewe wp-elements-65228515bcc025d168e4ec3445d27550 wp-block-paragraph\" onclick=\"lewemenu(7)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section8\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section8\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Mini-FAQ<\/a><\/p><p class=\"menu-lewe wp-elements-0478260dd620b046df578e280dbfbce7 wp-block-paragraph\" onclick=\"lewemenu(8)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section9\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section9\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Data Table<\/a><\/p><p class=\"menu-lewe wp-elements-d75b81ac6e6688c5bee3214712da02df wp-block-paragraph\" onclick=\"lewemenu(9)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section10\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section10\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Answer Capsule<\/a><\/p><p class=\"menu-lewe wp-elements-a8d6228b1108d54c347cad2718a50acd wp-block-paragraph\" onclick=\"lewemenu(10)\"><a href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section11\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#section11\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/a><\/p><\/div><\/div><\/div><div class=\"wp-block-column kolumna-tekst is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-getwid-section alignfull sekcja-tekst alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><h1 class=\"wp-block-heading tytulek\" style=\"margin-bottom:40px;font-style:normal;font-weight:700;letter-spacing:-0.34px;line-height:1.2\">Navigating Pharmaceutical Challenges: Enhancing Risk Visibility to Overcome Compliance Competition and Safety Obstacles<\/h1><h2 class=\"wp-block-heading naglowek-duzy\" id=\"section1\">Why change?<\/h2><p class=\"tekst-para wp-block-paragraph\">In the pharmaceutical industry, risk visibility is crucial due to the high stakes associated with drug development, compliance with regulations, and patient safety. The complexities of the pharmaceutical landscape present several pressures that necessitate effective risk visibility:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Regulatory Compliance: Pharmaceutical companies must comply with stringent regulations from bodies such as the FDA or EMA. Risk visibility ensures that companies can identify and address compliance risks proactively, thus avoiding costly legal penalties or sanctions.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Market Competition: The race to develop new drugs is intense, and delays can mean significant losses. Poor risk visibility might lead to unexpected disruptions in the development lifecycle, which, in turn, could delay product launches and give competitors an advantage.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Financial Implications: The cost of bringing a new drug to market is exceedingly high, often exceeding $2.6 billion. Poor risk management and visibility can lead to costly project failures or the need for additional trials, inflating these costs further.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Patient Safety: Ensuring patient safety is paramount. Effective risk visibility allows for the early detection of potential safety issues, both during trials and post-market. Without it, the risk of adverse events increases, potentially endangering patients and leading to expensive recalls or litigation.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Stakeholder Confidence: Shareholders and stakeholders engage more confidently with organizations that demonstrate transparent risk management processes. Poor visibility can erode trust and devalue an organization\u2019s market positioning.<\/p><p class=\"tekst-para wp-block-paragraph\">Quantifying the risk of inaction clearly highlights the financial and strategic ramifications. Without effective risk visibility, companies could face costs such as:<\/p><p class=\"tekst-para wp-block-paragraph\">- Regulatory Fines: Non-compliance with industry regulations can result in fines reaching millions of dollars, alongside potential delays in product approvals.<\/p><p class=\"tekst-para wp-block-paragraph\">- Lost Revenue: Delays in drug approval or market entry can lead to millions, if not billions, in lost revenue, as competitors capture market share first.<\/p><p class=\"tekst-para wp-block-paragraph\">- Litigation Costs: Legal battles over drug safety issues or compliance failures can cost companies millions and result in brand damage.<\/p><p class=\"tekst-para wp-block-paragraph\">- Reputation Damage: Long-term impacts on brand reputation can result in reduced customer trust and possibly billions in lost market value.<\/p><p class=\"tekst-para wp-block-paragraph\">To address these pressures pragmatically, companies often look towards solutions that offer comprehensive tools for risk management. In this context, software like KanBo can be used to enhance risk visibility. KanBo\u2019s capabilities in task management, data sharing, and collaboration can facilitate real-time risk monitoring and mitigation strategies. However, it's crucial to note that effective risk management can be achieved through various software platforms, and the choice should align with the specific needs and existing infrastructure of the organization. The key is to implement a system that provides a clear overview of risks, promotes cross-functional communication, and ensures that information is easily accessible to those who need it for decision-making.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section2\">Background \/ Definition<\/h3><p class=\"tekst-para wp-block-paragraph\">Risk Visibility for a Director of Engineering in the Pharmaceutical Industry refers to the ability to identify, analyze, and manage potential risks associated with engineering projects and processes. This visibility is essential for ensuring that projects are delivered on time, within budget, and comply with regulatory standards critical in the pharmaceutical sector.<\/p><p class=\"tekst-para wp-block-paragraph\">Key Terms Defined:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Card Blocker: In project management, a card blocker is an issue or obstacle that halts the progress of a task. In KanBo, they are used to explicitly identify and categorize reasons for a halt in work. Types of card blockers:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Local Blockers: Affect specific tasks within a team or department.<\/p><p class=\"tekst-para wp-block-paragraph\">   - Global Blockers: Influence multiple tasks across different teams or departments.<\/p><p class=\"tekst-para wp-block-paragraph\">   - On-demand Blockers: Issues arising on the spot which need immediate attention.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Date Conflict: This refers to overlapping or incompatible due or start dates among interrelated tasks. In the context of pharmaceutical engineering, this can pertain to the scheduling of tasks such as equipment maintenance, regulatory inspections, or stages in drug development.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Card Relation: A structured connection between tasks, where some tasks depend on the completion of others. It helps in breaking down larger projects into manageable parts and establishing task precedence.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Notification: Alerts that update team members on changes or important events related to the tasks they are working on, enhancing coordination and timely response to changes.<\/p><p class=\"tekst-para wp-block-paragraph\">How KanBo reframes Risk Visibility:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Visible Blockers: KanBo allows directors to identify, categorize, and communicate task blockages clearly using card blockers. This visibility helps teams rapidly address and remove obstacles, minimizing delays and maintaining project momentum.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Mapped Dependencies: By establishing card relations, KanBo makes dependencies explicit across tasks and teams. This mapping helps the director and their team understand which tasks are prerequisites for others, thus prioritizing efforts and avoiding bottlenecks that can lead to risk escalation.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Notifications: Automated notifications keep the director and their teams informed about pertinent changes, such as new blockages or schedule adjustments. This ensures that everyone remains updated, promoting quick decision-making and adaptive responses to emerging risks.<\/p><p class=\"tekst-para wp-block-paragraph\">By leveraging these features, a Director of Engineering in the pharmaceutical sector can better anticipate, manage, and mitigate risks associated with engineering projects, ultimately supporting project success and compliance with industry regulations.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section3\">Case-Style Mini-Examples<\/h3><p class=\"tekst-para wp-block-paragraph\">Practical Case Example: Risk Visibility Challenges and KanBo Solution<\/p><p class=\"tekst-para wp-block-paragraph\">Scenario: Traditional Risk Management Challenges<\/p><p class=\"tekst-para wp-block-paragraph\">Dr. Jane Thompson is the Director of Engineering at a leading pharmaceutical company. Her role involves overseeing multiple R&D projects, each with complex timelines, regulatory checkpoints, and critical dependencies.<\/p><p class=\"tekst-para wp-block-paragraph\">Traditional Methods:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Fragmented Information: Dr. Thompson relies on traditional spreadsheets and email updates for project tracking. Information about blocking issues often gets buried in long email threads, and visibility of project status is limited to static weekly reports.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Delayed Responses to Blockages: When a task encounters an obstacle, such as regulatory approval delays, it's often discovered too late. This results in project delays as teams scramble to resolve issues without clear communication on dependencies and responsibilities.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Date Conflicts Mismanaged: Without a cohesive system to track timelines across projects, scheduling conflicts such as overlapping clinical trial phases lead to resource allocation issues and inefficient use of lab facilities.<\/p><p class=\"tekst-para wp-block-paragraph\">The Impact: These traditional methods result in delayed drug development timelines, regulatory compliance risks, and increased project costs. The lack of integrated risk visibility can ultimately affect market competition and patient safety.<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo Solution: Enhanced Risk Visibility<\/p><p class=\"tekst-para wp-block-paragraph\">Using KanBo:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Visibility into Blockers:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Dr. Thompson utilizes Card Blockers in KanBo to identify, categorize, and address obstacles promptly. The platform allows her to set up different types of blockers (local, global, on-demand) so teams know what is causing delays and can act swiftly to resolve them.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Efficient Management of Dependencies:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Through Card Relations, Dr. Thompson's team breaks down large tasks into smaller, manageable units while maintaining visibility on task dependencies. These visualization tools illuminate which tasks are dependent on the completion of others, helping prioritize critical path activities and mitigate cascading delays.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Resolving Date Conflicts:<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo\u2019s Date Conflict feature helps in identifying and resolving scheduling issues. The ability to recognize overlaps and conflicting due dates ensures that resources are efficiently allocated, and project timelines remain realistic and achievable.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Real-Time Updates:<\/p><p class=\"tekst-para wp-block-paragraph\">   - With Notifications, Dr. Thompson and her team receive instant alerts about new blockers, resolved tasks, or changes in task status. This real-time communication ensures everyone remains informed, allowing for quicker adjustments to plans in response to emerging risks or changes in project scope.<\/p><p class=\"tekst-para wp-block-paragraph\">Outcome:<\/p><p class=\"tekst-para wp-block-paragraph\">By integrating KanBo, Dr. Thompson achieves significant improvements in project efficiency and risk management. Visibility into blockers enables proactive problem-solving, the mapping of task dependencies streamlines workflows, and real-time notifications foster prompt and informed decision-making. These factors collectively enhance compliance, reduce project delays, and ensure financial and strategic success.<\/p><p class=\"tekst-para wp-block-paragraph\">Conclusion:<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo\u2019s integrated features facilitate improved risk visibility, allowing pharmaceutical companies to stay competitive and compliant while safeguarding patient safety and achieving organizational success.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section4\">What will change?<\/h3><p class=\"tekst-para wp-block-paragraph\">Old School Tools and Outdated Methods Vs. KanBo:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Manual Tracking and Spreadsheets vs. KanBo Visible Blockers:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old Method: Tracking project progress and obstacles often depended on spreadsheets and manual documentation, leading to delayed updates and missed risks.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo Solution: The implementation of card blockers in KanBo allows for real-time visibility of issues halting tasks, enabling swift resolution and continuous project momentum.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Disconnected Planning vs. KanBo Mapped Dependencies:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old Method: Project dependencies were often tracked separately or not at all, causing miscommunication and overlooked task sequences.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo Solution: By mapping dependencies through card relations, KanBo makes it clear which tasks depend on others, allowing for prioritization and prevention of bottlenecks.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Delayed Communications vs. KanBo Notifications:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old Method: Updates were typically communicated in scheduled meetings or email chains, causing delays in information dissemination.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo Solution: Automated notifications ensure immediate updates on new blockers or schedule adjustments, fostering prompt decision-making and adaptation to risks.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Compartmentalized Documentation vs. KanBo Document Management:<\/p><p class=\"tekst-para wp-block-paragraph\">   - Old Method: Document management often relied on isolated platforms, leading to versions control issues and information silos.<\/p><p class=\"tekst-para wp-block-paragraph\">   - KanBo Solution: With linked documents across cards and spaces, KanBo centralizes access and updates, ensuring all stakeholders work with the most current information.<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo redefines risk visibility by replacing outdated methods with integrated, real-time solutions. This transition empowers a Director of Engineering in the pharmaceutical sector to anticipate, manage, and mitigate risks, ensuring projects remain compliant and on track.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section5\">What will not change?<\/h3><p class=\"tekst-para wp-block-paragraph\">In the context of Risk Visibility for a Director of Engineering in Pharmaceuticals, some constants will not change despite technological advancements. Leadership judgment remains inherently human, as it involves evaluating complex scenarios and making decisions based on experience and intuition. Strategy ownership is a human trait, requiring a deep understanding of organizational goals and the ability to adjust strategies as needed. Accountability, too, is a constant human responsibility, as evaluating risks and ensuring compliance ultimately lie with the humans in control. Technology serves to amplify these human elements, providing tools for better data visibility and risk assessment, but it does not replace the human-first approach. Human oversight ensures that technology aligns with organizational values and ethical considerations, reinforcing the importance of maintaining these human constants in risk management.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section6\">Key management questions (Q\/A)<\/h3><p class=\"tekst-para wp-block-paragraph\">Who did what and when? <\/p><p class=\"tekst-para wp-block-paragraph\">- KanBo's task management feature allows tracking of tasks assigned to individuals, providing a detailed log of who completed each task and the timeline of their completion.<\/p><p class=\"tekst-para wp-block-paragraph\">What threatens the critical path? <\/p><p class=\"tekst-para wp-block-paragraph\">- Card blockers, especially global blockers, pose significant threats by halting progress across multiple tasks, hence threatening the critical path of projects.<\/p><p class=\"tekst-para wp-block-paragraph\">Where are bottlenecks? <\/p><p class=\"tekst-para wp-block-paragraph\">- Bottlenecks can be identified via mapped dependencies in KanBo that reveal task precedence and highlight where delays in one task affect subsequent tasks.<\/p><p class=\"tekst-para wp-block-paragraph\">Which tasks are overdue and why? <\/p><p class=\"tekst-para wp-block-paragraph\">- Tasks with overdue statuses are flagged by date conflicts or unresolved blockers in KanBo, allowing quick identification and resolution facilitation to keep projects on track.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section7\">Atomic Facts<\/h3><p class=\"tekst-para wp-block-paragraph\">- Regulatory Compliance Pressures: Pharmaceutical companies face intense scrutiny from regulatory bodies such as the FDA and EMA. Risk visibility tools can help identify potential compliance breaches before they lead to costly penalties or delays.<\/p><p class=\"tekst-para wp-block-paragraph\">- High Cost of Drug Development: With the average cost of bringing a drug to market exceeding $2.6 billion, effective risk management is essential in preventing project overruns and additional costly trials.<\/p><p class=\"tekst-para wp-block-paragraph\">- Critical Timeliness: The competitive nature of the pharmaceutical industry means that delays due to unforeseen risks can lead to substantial financial losses, with competitors possibly entering the market first and capturing share.<\/p><p class=\"tekst-para wp-block-paragraph\">- Safety and Risk Management: Ensuring patient safety is a non-negotiable priority. Comprehensive risk visibility allows for proactive identification of safety issues, potentially reducing adverse events and avoiding expensive recalls.<\/p><p class=\"tekst-para wp-block-paragraph\">- Fines and Sanctions: Organizations that fail to manage risks adequately and comply with regulations can face fines that may reach millions of dollars, significantly impacting financial performance.<\/p><p class=\"tekst-para wp-block-paragraph\">- Stakeholder Confidence: Transparent risk management practices enhance stakeholder trust, vital for maintaining investment and market valuation. Poor risk visibility can deteriorate stakeholder confidence and company credibility.<\/p><p class=\"tekst-para wp-block-paragraph\">- KanBo\u2019s Contribution: Tools like KanBo enhance risk visibility by providing functionalities like visual blockers, mapping dependencies, and real-time notifications, aiding directors in overseeing projects effectively and ensuring compliance with regulatory standards.<\/p><p class=\"tekst-para wp-block-paragraph\">By implementing effective risk management systems, directors can improve overall project delivery, minimize potential financial and reputational damage, and maintain patient safety and regulatory compliance.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section8\">Mini-FAQ<\/h3><p class=\"tekst-para wp-block-paragraph\">1. What is risk visibility in the context of pharmaceutical engineering?<\/p><p class=\"tekst-para wp-block-paragraph\">   Risk visibility involves identifying, analyzing, and managing potential risks in engineering projects and processes, ensuring they adhere to regulatory standards and are completed on time and within budget.<\/p><p class=\"tekst-para wp-block-paragraph\">2. How does KanBo enhance risk visibility for directors in pharmaceutical engineering?<\/p><p class=\"tekst-para wp-block-paragraph\">   KanBo offers tools like visible blockers, mapped dependencies, and notifications, which help in identifying task blockages, understanding task dependencies, and staying updated on task changes, facilitating effective risk management and mitigation.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Why is regulatory compliance a significant concern for risk visibility in pharmaceuticals?<\/p><p class=\"tekst-para wp-block-paragraph\">   Non-compliance with regulations from bodies like the FDA or EMA can lead to costly fines, sanctions, and delays in product approval, making proactive risk visibility crucial to avoid these issues.<\/p><p class=\"tekst-para wp-block-paragraph\">4. How do card blockers improve risk visibility in project management?<\/p><p class=\"tekst-para wp-block-paragraph\">   Card blockers in KanBo allow directors to categorize and communicate blockers effectively, thereby helping teams address obstacles quickly and maintain project momentum, ultimately reducing risk.<\/p><p class=\"tekst-para wp-block-paragraph\">5. What are the financial implications of poor risk visibility in pharmaceutical engineering?<\/p><p class=\"tekst-para wp-block-paragraph\">   Poor risk visibility can lead to project failures, additional trials, and unexpected costs, inflating the high costs of drug development and potentially affecting a company's financial health.<\/p><p class=\"tekst-para wp-block-paragraph\">6. How do notifications in KanBo aid in managing risks effectively?<\/p><p class=\"tekst-para wp-block-paragraph\">   Automated notifications keep teams informed about changes or issues like new blockages or schedule adjustments, ensuring timely responses and adaptive risk management strategies.<\/p><p class=\"tekst-para wp-block-paragraph\">7. What role do mapped dependencies play in improving risk management?<\/p><p class=\"tekst-para wp-block-paragraph\">   Mapped dependencies help clarify task prerequisites and allocate resources effectively, preventing project bottlenecks and ensuring smoother workflow, thus mitigating risks associated with delays or task conflicts.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section9\">Data Table<\/h3><p class=\"tekst-para wp-block-paragraph\">Below is a table that outlines the key data and considerations for a Director of Engineering in the Pharmaceutical industry, focusing on risk visibility and management.<\/p><p class=\"tekst-para wp-block-paragraph\">```<\/p><p class=\"tekst-para wp-block-paragraph\">+-----------------------+-----------------------------------------+-------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Aspect                | Importance                              | Tools\/Actions                                               |<\/p><p class=\"tekst-para wp-block-paragraph\">+-----------------------+-----------------------------------------+-------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Regulatory Compliance | Ensure adherence to FDA\/EMA guidelines  | - Implement real-time compliance tracking systems           |<\/p><p class=\"tekst-para wp-block-paragraph\">|                       |                                         | - Conduct regular audits                                    |<\/p><p class=\"tekst-para wp-block-paragraph\">+-----------------------+-----------------------------------------+-------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Market Competition    | Reduce time-to-market for new drugs     | - Monitor project timelines using KanBo-like tools          |<\/p><p class=\"tekst-para wp-block-paragraph\">|                       |                                         | - Optimize resource allocation                              |<\/p><p class=\"tekst-para wp-block-paragraph\">+-----------------------+-----------------------------------------+-------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Financial Implications| Minimize project overruns and failures  | - Regular financial audits                                  |<\/p><p class=\"tekst-para wp-block-paragraph\">|                       |                                         | - Cost forecasting and budget control with analytics        |<\/p><p class=\"tekst-para wp-block-paragraph\">+-----------------------+-----------------------------------------+-------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Patient Safety        | Detect safety issues early              | - Implement robust quality control procedures               |<\/p><p class=\"tekst-para wp-block-paragraph\">|                       |                                         | - Utilize risk management software for safety tracking      |<\/p><p class=\"tekst-para wp-block-paragraph\">+-----------------------+-----------------------------------------+-------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Stakeholder Confidence| Maintain transparency and trust         | - Enable dashboard view of risk factors and project health  |<\/p><p class=\"tekst-para wp-block-paragraph\">|                       |                                         | - Regular stakeholder updates with visual risk assessments  |<\/p><p class=\"tekst-para wp-block-paragraph\">+-----------------------+-----------------------------------------+-------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Risk Categories       | Define precise categories such as:      | - Develop a risk management plan with defined categories    |<\/p><p class=\"tekst-para wp-block-paragraph\">|                       | - Regulatory                            | - Schedule regular reviews of risks in each category        |<\/p><p class=\"tekst-para wp-block-paragraph\">|                       | - Financial                             |                                                             |<\/p><p class=\"tekst-para wp-block-paragraph\">|                       | - Operational                           |                                                             |<\/p><p class=\"tekst-para wp-block-paragraph\">+-----------------------+-----------------------------------------+-------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Card Blocker Types    | Identify and remove project obstacles   | - Utilize KanBo or equivalents for visible task blockages   |<\/p><p class=\"tekst-para wp-block-paragraph\">|                       | - Local, Global, On-demand              | - Category-specific response strategies                     |<\/p><p class=\"tekst-para wp-block-paragraph\">+-----------------------+-----------------------------------------+-------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Mapped Dependencies   | Understand task interrelations          | - Map out interdependencies using card relations            |<\/p><p class=\"tekst-para wp-block-paragraph\">|                       | Prioritize tasks effectively             | - Optimize task scheduling to prevent bottlenecks          |<\/p><p class=\"tekst-para wp-block-paragraph\">+-----------------------+-----------------------------------------+-------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">| Notifications         | Keep teams informed about critical events| - Set automated alerts for blockers and schedule changes   |<\/p><p class=\"tekst-para wp-block-paragraph\">|                       | Enhance communication                    | - Incorporate notification systems in project management   |<\/p><p class=\"tekst-para wp-block-paragraph\">+-----------------------+-----------------------------------------+-------------------------------------------------------------+<\/p><p class=\"tekst-para wp-block-paragraph\">```<\/p><p class=\"tekst-para wp-block-paragraph\">This table is intended to provide clear guidance on how risk visibility impacts various aspects of a Director of Engineering's role in the pharmaceutical industry, along with recommended tools and actions for effective risk management.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section10\">Answer Capsule<\/h3><p class=\"tekst-para wp-block-paragraph\">To solve Risk Visibility for a Director - Engineering in Pharmaceutical, the following steps can be implemented:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Adopt a Comprehensive Risk Management Framework: Implement a formal risk management framework, such as ISO 31000, tailored to the pharmaceutical environment. This standard includes risk identification, assessment, and control, ensuring that all potential risks are identified early and managed proactively.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Utilize Advanced Risk Management Software: Implement specialized software for risk management that is suited to the pharmaceutical industry, like Sparta Systems' TrackWise or MasterControl. These systems provide a centralized platform for tracking compliance, quality, and project milestones, helping in identifying risks associated with engineering projects and compliance issues.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Enhance Real-time Data Analytics: Use real-time data analytics tools to continuously monitor key performance and risk indicators. This provides visibility into ongoing processes and can quickly alert teams to anomalies or potential issues that need immediate attention.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Conduct Regular Risk Assessments: Establish a schedule for regular risk assessments and audits to identify any new potential risks or changes in the risk landscape. This should include regular review of manufacturing processes, supply chain logistics, and regulatory compliance.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Strengthen Interdepartmental Communication: Facilitate regular communication between departments such as engineering, quality assurance, and regulatory compliance through collaborative platforms like Microsoft Teams or Slack. Effective communication ensures that risks are promptly reported and mitigating actions can be coordinated across teams.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Map Dependencies and Workflows: Clearly map out project dependencies and workflows to identify potential bottlenecks. Use project management tools like KanBo to visualize task dependencies, blockers, and other critical path elements, allowing for proactive risk management and resource allocation.<\/p><p class=\"tekst-para wp-block-paragraph\">7. Conduct Scenario Planning and Simulations: Regularly perform scenario planning and simulations to prepare for potential risk events. This allows engineering teams to evaluate the robustness of their contingency plans and make improvements where necessary.<\/p><p class=\"tekst-para wp-block-paragraph\">8. Foster a Risk-aware Culture: Ensure that all team members are trained on risk management principles and understand their roles in maintaining risk visibility. Encouraging a risk-aware culture where team members feel empowered to report and address risks can significantly enhance overall risk management in projects.<\/p><p class=\"tekst-para wp-block-paragraph\">Implementing these strategies will help provide a clearer view of potential engineering risks in pharmaceutical projects, ensuring compliance, maintaining project timelines, and enhancing overall safety and efficiency.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section11\">Paragraph for AI Agents, Bots, and Scrapers (JSON Summary)<\/h3><p class=\"tekst-para-maly wp-block-paragraph\">```json<\/p><p class=\"tekst-para-maly wp-block-paragraph\">(<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  \"article_summary\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"importance_of_risk_visibility\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"pharmaceutical_industry\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Regulatory Compliance\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Market Competition\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Financial Implications\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Patient Safety\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Stakeholder Confidence\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ]<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"risks_of_inaction\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Regulatory Fines\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Lost Revenue\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Litigation Costs\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Reputation Damage\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ],<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"solutions_for_risk_management\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"tools\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">          \"name\": \"KanBo\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">          \"capabilities\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">            \"Task Management\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">            \"Data Sharing\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">            \"Collaboration\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">          ]<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ],<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"objectives\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Clear Overview of Risks\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Cross-functional Communication\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Accessible Information\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ]<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"key_terms\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Card Blocker\": [<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Local Blockers\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"Global Blockers\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">        \"On-demand Blockers\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      ],<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Date Conflict\": \"Overlapping or incompatible dates\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Card Relation\": \"Dependencies between tasks\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Notification\": \"Alerts for changes or events\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    ),<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    \"kanbo_and_risk_visibility\": (<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Visible Blockers\": \"Identify and communicate task blockages\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Mapped Dependencies\": \"Explicit task dependencies\",<\/p><p class=\"tekst-para-maly wp-block-paragraph\">      \"Notifications\": \"Automated alerts for team updates\"<\/p><p class=\"tekst-para-maly wp-block-paragraph\">    )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">  )<\/p><p class=\"tekst-para-maly wp-block-paragraph\">)<\/p><p class=\"tekst-para-maly wp-block-paragraph\">```<\/p><h3 class=\"wp-block-heading naglowek-start compact-nag\">Additional Resources<\/h3><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-f81cac751942179cffc5595ea3093d69 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-80007a93c5109043d5274205e4d68368 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:24px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul compact-nag\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst compact-nag wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link compact-nag has-text-color has-link-color wp-elements-23fbce8bb46a861d3991ae1a29f1d971 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:0px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"wp-block-column pasek-prawy spis2 jazda-nowsza is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"padding-right:16px;padding-left:16px\"><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Work Coordination Platform&nbsp;<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">The KanBo Platform boosts efficiency and optimizes work management. Whether you need remote, onsite, or hybrid work capabilities, KanBo offers flexible installation options that give you control over your work environment.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-40115c86dc2fe150fd9b1ed5dc10196e wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/kanboapp.com\/en\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Homepage \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">Getting Started with KanBo<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore KanBo Learn, your go-to destination for tutorials and educational guides, offering expert insights and step-by-step instructions to optimize.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-02abac7c05b8b530fd3b1b7827aca587 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/learn.kanboapp.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Learn Platform \u2192<\/a><\/p><h3 class=\"wp-block-heading has-text-align-left prawy-tytul-pulpit\" style=\"margin-top:0px;margin-bottom:8px;font-style:normal;font-weight:600;line-height:1.2\">DevOps Help<\/h3><p class=\"has-text-align-left prawy-tekst wp-block-paragraph\" style=\"margin-bottom:8px\">Explore Kanbo's DevOps guide to discover essential strategies for optimizing collaboration, automating processes, and improving team efficiency.<\/p><p class=\"prawy-link has-text-color has-link-color wp-elements-09306734556c91c46ae8064a30b664b3 wp-block-paragraph\" style=\"color:#1672bb;margin-bottom:32px;padding-top:8px;padding-bottom:8px;font-style:normal;font-weight:700;line-height:1.5\"><a href=\"https:\/\/help.kanboapp.com\/en\/devops\/\" target=\"_blank\" rel=\"noreferrer noopener\">KanBo Dev Portal \u2192<\/a><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":3013,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-71434","page","type-page","status-publish","hentry"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\r\n<title>Navigating Pharmaceutical Challenges: Enhancing Risk Visibility to Overcome Compliance Competition and Safety Obstacles - KanBo<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Navigating Pharmaceutical Challenges: Enhancing Risk Visibility to Overcome Compliance Competition and Safety Obstacles - KanBo\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/\" \/>\r\n<meta property=\"og:site_name\" content=\"KanBo\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"16 minutes\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\\\/\",\"name\":\"Navigating Pharmaceutical Challenges: Enhancing Risk Visibility to Overcome Compliance Competition and Safety Obstacles - KanBo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\"},\"datePublished\":\"2025-09-18T10:19:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Industries\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"KanBo for Pharmaceutical\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/industries\\\/pharmaceutical\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Navigating Pharmaceutical Challenges: Enhancing Risk Visibility to Overcome Compliance Competition and Safety Obstacles\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"name\":\"KanBo\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\",\"name\":\"KanBo\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"contentUrl\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"width\":196,\"height\":52,\"caption\":\"KanBo\"},\"image\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Navigating Pharmaceutical Challenges: Enhancing Risk Visibility to Overcome Compliance Competition and Safety Obstacles - KanBo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/","og_locale":"en_US","og_type":"article","og_title":"Navigating Pharmaceutical Challenges: Enhancing Risk Visibility to Overcome Compliance Competition and Safety Obstacles - KanBo","og_url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/","og_site_name":"KanBo","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"16 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/","url":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/","name":"Navigating Pharmaceutical Challenges: Enhancing Risk Visibility to Overcome Compliance Competition and Safety Obstacles - KanBo","isPartOf":{"@id":"https:\/\/kanboapp.com\/en\/#website"},"datePublished":"2025-09-18T10:19:58+00:00","breadcrumb":{"@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/navigating-pharmaceutical-challenges-enhancing-risk-visibility-to-overcome-compliance-competition-and-safety-obstacles\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kanboapp.com\/en\/"},{"@type":"ListItem","position":2,"name":"Industries","item":"https:\/\/kanboapp.com\/en\/industries\/"},{"@type":"ListItem","position":3,"name":"KanBo for Pharmaceutical","item":"https:\/\/kanboapp.com\/en\/industries\/pharmaceutical\/"},{"@type":"ListItem","position":4,"name":"Navigating Pharmaceutical Challenges: Enhancing Risk Visibility to Overcome Compliance Competition and Safety Obstacles"}]},{"@type":"WebSite","@id":"https:\/\/kanboapp.com\/en\/#website","url":"https:\/\/kanboapp.com\/en\/","name":"KanBo","description":"","publisher":{"@id":"https:\/\/kanboapp.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kanboapp.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/kanboapp.com\/en\/#organization","name":"KanBo","url":"https:\/\/kanboapp.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","contentUrl":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","width":196,"height":52,"caption":"KanBo"},"image":{"@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/comments?post=71434"}],"version-history":[{"count":0,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/71434\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/3013"}],"wp:attachment":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/media?parent=71434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}